Anebulo Pharmaceuticals Inc (ANEB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 12-2020 | 09-2020 | 06-2020 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 0 | 0 | 3,025 |
| Receivables | 0 | 0 | 4 |
| Other current assets | 0 | 0 | -1 |
| TOTAL | $0 | $0 | $3,028 |
| Non-Current Assets | |||
| TOTAL | $N/A | $N/A | $N/A |
| Total Assets | $0 | $0 | $3,028 |
| Liabilities | |||
| Current Liabilities | |||
| Accrued Expenses | 0 | 0 | 23 |
| TOTAL | $0 | $0 | $224 |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 0 | 0 | 2,976 |
| TOTAL | $N/A | $N/A | $2,976 |
| Total Liabilities | $0 | $0 | $3,200 |
| Shareholders' Equity | |||
| Common Shares | 0 | 0 | 12 |
| Retained earnings | 0 | 0 | -183 |
| TOTAL | $0 | $0 | $-171 |
| Total Liabilities And Equity | $0 | $0 | $3,029 |